Mechanism of Action: Adenosine Receptor Agonists
✉ Email this page to a colleague
Drugs with Mechanism of Action: Adenosine Receptor Agonists
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Avet Lifesciences | ADENOSINE | adenosine | SOLUTION;INTRAVENOUS | 202313-001 | Sep 15, 2014 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Fresenius Kabi Usa | ADENOSINE | adenosine | SOLUTION;INTRAVENOUS | 077897-001 | Nov 27, 2017 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Avet Lifesciences | ADENOSINE | adenosine | SOLUTION;INTRAVENOUS | 202313-002 | Sep 15, 2014 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Fresenius Kabi Usa | ADENOSINE | adenosine | SOLUTION;INTRAVENOUS | 077897-002 | Nov 27, 2017 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Hospira | ADENOSINE | adenosine | SOLUTION;INTRAVENOUS | 203883-001 | Mar 24, 2014 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Fresenius Kabi Usa | ADENOSINE | adenosine | INJECTABLE;INJECTION | 205568-001 | Apr 16, 2018 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Rising | ADENOSINE | adenosine | INJECTABLE;INJECTION | 078076-001 | Oct 31, 2008 | AP | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
